Frequently Asked Questions

1. What makes Project Globe different?

Project Globe’s “Integrated Management of Chronic Disease and Risk Factor Control Program” (IM-Cardio) presents an innovative treatment paradigm that assists primary care physicians to change their practice behaviors enabling them to consistently and effectively treat and manage chronic disease and its risk factors, as well as reduce high rates of disability and premature death.

Project Globe’s distinguishes itself from other the chronic and acute disease by focusing on:

  1. A multi-factor disease management system that greatly facilitates implementation of the five essentials needed for the successful control and management of chronic disease:
    1. Prevention
    2. Screening and early detection
    3. Diagnosis and treatment of multiple risk factors with appropriate medicines
    4. Self-management and treatment adherence support
    5. Continuing follow-up care and management
  2. Patient-centered care skill training that stresses the importance of empathy and communication in developing an effective doctor patient relationship. Physicians who complete the course hone their patient communication and relationship skill learning to assist patients to better understand their condition, effectively explore treatment options and commit to a treatment adherence plan that works for them.
  3. Culturally-adapted educational materials that enhance understanding and answer many questions patients and their families may have about the prevention and treatment of their condition.
  4. The poor and vulnerable and closing the health care quality and outcomes gap between socioeconomic groups. The poor and vulnerable suffer 2-3 times the risk of serious chronic illness and have a 10-fold difference in premature CVD and up to a 20-year difference in healthy life expectancy compared to higher socioeconomic groups.

Primary care physicians who complete a Project Globe program are able to integrate the management of chronic disease risk factors and their underlying determinants and strengthen health systems with view toward systematically helping to reduce inequalities.

2. Where will this initiative take place? (Country; region; etc)

Initial Phase:

  • The Russian Federation
  • Venezuela

Expansion Phase:

  • Colombia
  • Egypt
  • Turkey

The initial phase will take place in four policlinics in Metropolitan Moscow in the Russian Federation and online and in over forty clinics in Venezuela.

3. How many physicians/caregivers will be impacted by Project Globe?

In the first wave of the project, 73 primary care doctors in Russia will be impacted and 83 in Venezuela. We plan to expand the project, as funding allows, in both of these countries to include as many physicians as possible. The second wave will impact up to 5,000 physicians in each country.

As the project expands to additional countries, Project Globe expects a similar rate of impact on physicians resulting in an engagement of 100,000 physicians worldwide over the next five to seven years.

4. How many patients will be impacted in these first stages of the Project?

Country First Wave Second Wave Subsequent Waves
Russia 800 (40x20) 2000 3000+
Venezuela 1600 (80x20) 2000 3000+

5. What are the projected/anticipated beneficial outcomes?

Populations cared for by Project GLOBE trained physicians, screening and treating CVRF patients for high blood pressure alone, could expect to have 35-40% less chance of a fatal stroke, a 20-25% less chance of a fatal heart attack and a 50% less chance of heart failure.

From about 1.5-2.5 fewer deaths from cardiovascular disease could be expected for every 10 patients treated for hypertension alone.

Control of high cholesterol further reduces the risk of coronary artery disease and complications due to stroke, heart attack, heart failure, and risks of damage to end organs, e.g., heart, eyes, and kidneys.*

6. How will positive outcomes be sustained for the patients?

Project Globe’s IM-Cardio© Program, provides physicians with the needed skills and a system to continually and effectively track patient progress and schedule follow-up patient visits at 3, 6, and 12 month intervals. At each visit:

  1. Examinations andlab tests are conducted to assess patient progress compared to blood pressure, lipid and other goals specific to each patient.
  2. Physicians provide the same type of patient-centered care as during the initial visit and assess the patient’s overall satisfaction and adherence to their treatment self-care plan and life style change agreement.
  3. Physicians determine whether a change or modification in therapy may be required to reach and maintain blood pressure, lipid levels and other health goals.

The integrated continuous implementation of these three activities is the only proven approach to treating and effectively controlling chronic disease. Project Globe’s Integrated Management of Chronic Disease and Risk Factor Control Program address each in a comprehensive manner. Chronic conditions are not amenable to the same treatment methods as acute conditions. Successful treatment demands an ongoing vigilant partnership between physician and patient.

7. What is the specific role between of PG and its partner(s)?

Project GLOBE is the provider of comprehensive, integrated chronic disease management programs. Project GLOBE collaborates closely with its partners in the implementation and expansion of its programs in each country, modifies programs to meet local needs, monitors outcomes and publishes results.

8. How long will this project take to complete?

The online and live in-field training takes place over five months. The physicians’ tracking and follow-up of patients at 3, 6, and 12 months, and thereafter on a continuing basis, helps insure that Project GLOBE’s Integrated Management system becomes routine in the care of chronic disease and risk factor control.

9. Why do the doctors lack training?

While most primary care physicians emerge from medical school and other initial medical training well-skilled, the pace of change in medicine is so fast that a physician’s knowledge and skill needs continual updating. Many countries around the world currently lack effective systems for updating their practicing physicians. Often, this is a matter of lack of resources. In others, there is a lack of understanding of the critical nature of updating physician knowledge and skill. In the mix of priorities, chronic conditions like CVR are not always accorded the same sense of urgency as more acute conditions in spite of the fact that non-communicable/chronic diseases, such as diabetes, cardiovascular disease and chronic respiratory conditions are the leading causes of death and disability worldwide. Cardiovascular disease alone accounts for 50-60% of all deaths globally: making it the No. 1 killer.



* Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) 2004; Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomized trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet.2000; 356:1955-64; Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension.2000;35:539-43; Eddy DM, et al, The potential Effects of HEDIS Performance Measures on the Quality of Care, Health Affairs, Vol 27, No 5, 2008.

x